Ryan Long, the co-author of a recent USC Schaeffer Center white paper on the 340B Drug Pricing Program, argues that meaningful reform requires shifting to a direct subsidy model based on need. The ...

On July 31, 2025, notice was published in the Federal Register by the Health Resources and Services Administration (“HRSA”) of a “340B Rebate Model Pilot Program” (“340B Pilot Program”). The 340B ...

Reforming the federal 340B Drug Pricing Program is a fast and efficient way to reduce drug costs and protect patients. These days, some 340B hospitals are taking advantage of low-income and uninsured ...

The 340B Drug Pricing Program allows certain medical facilities to buy drugs at a discount to support care for low-income patients. Rhode Island's new law, Chapter 288, prevents drug makers from ...

Having served in both state and federal government, I know it is far too rare for elected officials to stand up to special interests with appropriate skepticism. That is why Michigan's House Speaker ...

At a recent Senate hearing, which refocused attention on the broken 340B Drug Pricing Program, lawmakers were reminded of how far the program has strayed from its original, humanitarian purpose. A ...

Drug companies are at it again. They will not relent in their multiyear campaign to dismantle the 340B Drug Pricing Program. Drug companies are at it again. They will not relent in their multiyear ...

The federal 340B Drug Pricing Program ("340B Program") was created by Congress in 1992 through an amendment to the Public Health Service Act. [i] The program, which is administered by the Health ...

The 340B Drug Pricing Program was created to help low-income patients access medications at reduced costs. Ryan Augsburger argues that expanding the program could increase costs for employers and ...

Central Ohio native Ryan Augsburger serves as president for the Ohio Manufacturers’ Association and its more than 1,300 member companies across Ohio. For many Ohio businesses, the word “expansion” ...